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Predictors of 30-day and 90-day mortality
among hemorrhagic and ischemic stroke
patients in urban Uganda: a prospective
hospital-based cohort study
Gertrude Namale1* , Onesmus Kamacooko1, Anthony Makhoba2, Timothy Mugabi2, Maria Ndagire2,
Proscovia Ssanyu2, John Bosco M. Ddamulira3, Laetitia Yperzeele4, Patrick Cras5, Edward Ddumba2,
Janet Seeley1,6 and Robert Newton1,7
Abstract
Background: We report here on a prospective hospital-based cohort study that investigates predictors of 30-day
and 90-day mortality and functional disability among Ugandan stroke patients.
Methods: Between December 2016 and March 2019, we enrolled consecutive hemorrhagic stroke and ischemic
stroke patients at St Francis Hospital Nsambya, Kampala, Uganda. The primary outcome measure was mortality at
30 and 90 days. The modified Ranking Scale wasused to assess the level of disability and mortality after stroke.
Stroke severity at admission was assessed using the National Institute of Health Stroke Scale (NIHSS) and Glasgow
Coma Scale (GCS). Examination included clinical neurological evaluation, laboratory tests and brain computed
tomography (CT) scan. Kaplan-Meier curves and multivariate Cox proportional hazard model were used for
unadjusted and adjusted analysis to predict mortality.
Results: We enrolled 141 patients; 48 (34%) were male, mean age was 63.2 (+ 15.4) years old; 90 (64%) had
ischemic and 51 (36%) had hemorrhagic stroke; 81 (57%) were elderly (≥ 60 years) patients. Overall mortality was 44
(31%); 31 (23%) patients died within the first 30 days post-stroke and, an additional 13 (14%) died within 90 days
post-stroke. Mortality for hemorrhagic stroke was 19 (37.3%) and 25 (27.8%) for ischemic stroke. After adjusting for
age and sex, a GCS score below < 9 (adjusted hazard ratio [aHR] =3.49, 95% CI: 1.39–8.75) was a significant
predictor of 30-day mortality. GCS score < 9 (aHR =4.34 (95% CI: 1.85–10.2), stroke severity (NIHSS ≥21) (aHR = 2.63,
95% CI: (1.68–10.5) and haemorrhagic stroke type (aHR = 2.30, 95% CI: 1.13–4.66) were significant predictors of 90-
day mortality. Shorter hospital stay of 7–13 days (aHR = 0.31, 95% CI: 0.11–0.93) and being married (aHR = 0.22 (95%
CI: 0.06–0.84) had protective effects for 30 and 90-day mortality respectively.
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Conclusion: Mortality is high in the acute and sub-acute phase of stroke. Low levels of consciousness at admission,
stroke severity, and hemorrhagic stroke were associated with increased higher mortality in this cohort of Ugandan
stroke patients. Being married provided a protective effect for 90-day mortality. Given the high mortality during the
acute phase, critically ill stroke patients would benefit from early interventions established as the post-stroke-
standard of care in the country.
Keywords: Hemorrhagic stroke, Ischemic stroke, Predictors, 30-day mortality, 90-day mortality, Glasgow coma scale
(GCS), Modified ranking scale (mRS), National Institute of health stroke scale (NIHSS), Uganda
Introduction
The trend towards an increasing burden of non-
communicable chronic diseases (NCDs) including stroke
in developing countries is of great concern [1]. The
World Health Organization (WHO) estimates that by
2030, 80% of all stroke will occur in people living in low
and middle income countries (LMICs), where it will ac-
count for 7.9% of all mortality [2, 3]. In sub-Saharan Af-
rica (SSA), the burden of stroke is increasing as the
population undergoes epidemiological and demographic
change [4]. In Uganda, stroke is estimated to be one of
the top five causes of adult deaths and accounts for 3.7%
of all hospital admissions among adults [3]. All-stroke
mortality from the available Ugandan hospital-based
studies, is estimated to be between 30 and 40% at
1 month [5, 6], which is much higher than the 20% mor-
tality reported in the rest of the world [7]. Hence, the in-
creasing burden of stroke in the SSA region will put a
huge burden on the already overstretched health care
system and resources [8].
Stroke related mortality varies considerably between
stroke types, regions and countries. For example in
Uganda, 30-day mortality was found to be 43% com-
pared to 27% in Gambia [6, 9]. While 90-day mortality
was estimated at 50% in Tanzania compared to 29.4% in
Korea [10, 11]. Furthermore, studies in Nigeria and
South Africa, indicated that overall mortality at 1 month
ranged between 30 and 35% [12, 13].. Reports have
shown that mortality rates increased with increasing age
and were higher for hemorrhagic stroke (HS) than for is-
chaemic stroke (IS) and, is often associated with a higher
risk of early death [9, 14]. Previous studies have linked
the excess mortality in patients with HS to more severe
strokes [11, 15]. In Dublin, using the modified Ranking
Scale (mRS), overall good outcome at 28 days was more
common in IS (44.4%) compared with HS (26.8%) [16].
Predictors of stroke mortality have been identified in
different studies [5, 9]. In Nigeria, 30-day mortality has
been associated with advanced age, low level of con-
sciousness on admission to hospital and higher National
Institute of Health Stroke Scale (NIHSS) score [13];
presence of comorbid conditions such as diabetes melli-
tus (DM) has been associated with a higher long term
mortality in Ghana [17]. In developing countries includ-
ing Uganda, resources for stroke care and rehabilitation
are still largely lacking particularly in lower health facil-
ities [8]. However, the WHO has emphasized the im-
portance of developing robust national surveillance
systems to monitor stroke frequency and outcomes par-
ticularly in developing countries [18].
In SSA, few epidemiologic studies of stroke have ex-
plored and compared the outcomes of HS and IS separ-
ately. Most of the published evidence is cross-sectional
with short-term follow-up [5, 6].
Methods
Aim, design and setting
We conducted a prospective hospital-based cohort study
between December 2016 and March 2019 to investigate
predictors of 30-day and 90-day mortality and functional
disability among HS and IS patients at Nsambya Hos-
pital, Kampala, Uganda. The hospital is a large urban
tertiary referral hospital, which lies approximately 5 km
southeast of Kampala, Uganda’s capital city. It receives
patients from all parts of the country and offers medical
care in all disciplines. Most of the patients pay personal
private fees for treatment, while a minority has medical
insurance covering the costs. Nsambya Hospital has
around 19, 000 admissions per year and receives about
300 outpatients per day.
Participants
The participants were patients who presented at Nsam-
bya hospital- Kampala within 7 days of the onset of
stroke symptoms, during the study period and, who met
the WHO stroke definition: rapidly developing clinical
signs of focal or global disturbance of cerebral function,
lasting for more than 24 h or until death, with no appar-
ent non-vascular cause [19] with neuro imaging con-
firmed stroke results.
Eligibility criteria
The eligibility criteria for participation in the study in-
cluded: 1) being an adult aged ≥18 years old; 2) con-
firmed cases of IS and HS on brain neuro-imaging; and
3) first-ever or recurrent stroke. We excluded
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participants who were: 1) unable to consent or for whom
consent could not be obtained from a caregiver; (2) un-
able to communicate and without a caregiver respond-
ent; (3) those who died within 24 h on the ward before
neuroimaging was done; and 4) those who presented
more than 7 days after onset of symptoms.
Study procedures
All consecutive patients aged ≥18 years old with a con-
firmed diagnosis of HS or IS stroke were enrolled pro-
spectively over a 2-year period. Both first-ever stroke
and recurrent stroke patients were included. The study
was based on the standardized WHO stepwise approach
to stroke surveillance (STEPS) [20]. All information was
collected by a trained medical team according to the
STEPS Stroke Manual Instructions [20]. Within 24 h of
admission, we obtained information about events that
occurred within 7 days after the stroke event. Data on
social demographic characteristics, social history, past
medical history, stroke severity, pre-stroke functional
ability, clinical characteristics and family history was col-
lected. If patients were unable to respond to questions,
family members served as proxy respondents. All partici-
pants underwent physical examination and assessment
including recording blood pressure, physical function
using a mRS [21] and neurological examination using
the NIHSS [21] and Glasgow Coma Scale (GCS). Com-
puted tomography (CT) scan was performed in all pa-
tients within the first 48 h after admission. Stroke types
were differentiated based on CT scan interpretations
into IS and HS.
Follow up
All study participants were followed up prospectively at
30 days and 90 days by the study team. Participants were
given an appointment to attend the neurology outpatient
clinic post-stroke. Patients or their family members were
contacted to remind them about the appointment date.
Patients who failed to attend the follow-up visits were
contacted and interviewed by telephone and, if not pos-
sible, their relatives were contacted, or a home visit was
carried out. Information about functional status at 30
and 90 days using the mRS, stroke recurrence, mortality,
mortality date and cause were recorded. Patients who
had missed their day 30 or day 90 follow-up visits and
did not present at the clinic within 30 days, and could
not be contacted by phone, were considered as ‘lost-to-
follow up’.
Measurements
The primary outcome of the study was mortality at 30
and 90 days, and mortality was defined as the number of
deaths among stroke patients which occurred within
these time limits. The primary outcome was assessed
using the mRS. For each patient, social demographic
data (age, sex, level of education and marital status), in-
formation about presence of hypertension, DM, smoking
habits, alcohol consumption, HIV infection, past medical
history and a family history of Hypertension, DM and
stroke were obtained. Hypertension was defined as either
current use of antihypertensive medication or history of
being diagnosed with hypertension prior to stroke or
documented blood pressure of greater than or equal to
140 mmHg systolic or 90 mmHg diastolic. Diabetes mel-
litus was defined as current use of antidiabetic drugs,
diagnose of type I or type II diabetes before stroke or a
documented non-fasting blood glucose of greater than
11.1 mmol/L or fasting blood glucose of greater than 7.0
mmol/L outside of the acute phase of stroke (to exclude
acute transient elevation of glucose as a stress response
after stroke). Premorbid functional status was assessed
using the mRS: (i) mRS 0–2 was considered good, (ii)
mRS 3 was fair, and (iii) 4–5 indicated poor outcome.
The length of hospital stay (LOS) for a single stroke
hospitalization was defined as the time spent in hospital
from admission until death or discharge to home. The
severity of the neurological deficit at admission was
assessed using the NIHSS. Higher figures correspond to
higher stroke severity: (i) NIHSS 0–6 was considered
mild; (ii) 7–12 was moderate; (iii) 13–20 was severe; (iv)
≥21 was very severe stroke. Level of consciousness was
assessed using the GCS: (i) Good GCS (13–15); mild
brain injury (alert), (ii) moderate GCS (9–12); moderate
brain injury (drowsy), (iii) poor GCS (< 9); severe brain
injury (unconscious).
Sample size estimation
A sample size of 140 participants was needed to assess
the primary outcome (30-day and 90-day mortality) of
this study. The sample size was based on an anticipated
35% mortality for each of the two mortality measures
[13]. An 80% power, 5% level of significance, 95% confi-
dence interval were assumed. The sample was adjusted
for a 10% rate of non-response. All eligible participants
were consecutively enrolled during the study period.
Data analysis
Data was double entered in OpenClinica (OC), cleaned,
and exported to Stata15.0 (StataCorp, College Station,
TX, USA) for analysis. We resolved discrepancies by
checking the source documents for clarification on all
possible confounders. Categorical demographic and clin-
ical characteristics were summarized by counts and per-
centages. Continuous variables were summarized by
means and standard deviations or medians and inter-
quartile ranges. We used the Kaplan-Meier technique to
estimate time to mortality after admission and presented
the estimated mortality rates per 1000 person-days for
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the study variables. To compare the mortality distribu-
tions between the groups for the different variables of
interest, a log rank test was used. Mortality rate was
assessed within 30 days and at 90 days of follow-up. Cox
proportional hazards regression was used to determine
independent predictors of mortality among participants
and these were expressed as estimated hazard ratios
(HRs) with their corresponding 95% confidence intervals
(CIs). In the bivariate proportional hazards analysis, vari-
ables significant at p ≤ 0.15 [22] were subsequently con-
sidered for the adjusted model. We considered age and
gender as priori confounders; these were included in the
adjusted model regardless of their unadjusted p values.
The P- values represented the differences in the variable
sub categories for 30- and 90-day mortality.
In adjusted modelling, variables whose p-value was less
than 0.05 were considered independent predictors of
stroke mortality. This was done both at 30 days and 90
days of follow-up. The proportional hazards assumption
was tested using graphical inspection and tests for time
trends of Schoenfeld residuals. In our model, we used a
full model regression procedure to build the model and
independent variables that were not significant at bivari-
ate but interesting were added if adding them did not
make the fit of the model significantly worse at the 5%
level on a likelihood ratio test.
Results
Participants’ recruitment and outcome assessment profile
During the study period, 153 stroke patients attending
Nsambya hospital were screened for eligibility. Of these,
12 (7%) were excluded: those who died within 24 h be-
fore CT scan was done (n = 4); those who had unspeci-
fied stroke (n = 2); those who had transient ischemic
attacks (n = 4) and those who presented more than 7
days after onset of symptoms (n = 2). Thus a total of 141
patients with confirmed IS or HS that consented for en-
rolment were included, of these five were lost to follow
up before outcome assessment at 30 days, 77 completed
the 90 days of follow-up, a total of 44 patients died
within 90 days post-stroke period (31 died between 0
and 30 days, while 13 died between > 30–90 days); 15
were lost to follow up between 30 and 90 days (Fig. 1).
Participants’ baseline characteristics
Of the 141 participants included in the analysis, 48
(34%) were male, mean age was 63.2 (+ 15.4) years old,
90 (64%) had IS, while 51 (36%) had HS; 65 (46%)
Fig. 1 Summary of recruitment and outcome assessment profile for hemorrhagic and ischemic stroke patients in Kampala, Uganda
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attained secondary education and above; 81 (57%) were ≥
60 years. The mean length of hospital stay was 9.4 (SD ±
10.7) days. Median time between the onset of symptoms
and medical attention for IS patients was higher (2 days
(Interquartile range [IQR]: 1–4 days) compared to HS (1
day [IQR]: 1–5 days) (Table 1). Overall mortality was 44
(31%); 31 (23%) patients died within the first 30 days
post-stroke and, an additional 13 (14%) died within 90
days post-stroke. The mean follow-up duration was 61
(SD ± 34) days, with a total of 8274 person days of follow
up at 90 days. The overall mortality for HS was 19
(37.3%) and 25 (27.8%) for IS (Table 2). Figure 2 shows
cumulative mortalities during the 3 months follow-up
period according to stroke type. We observed a statisti-
cally significant higher mortality rates among females
compared to males at 30 days (p = 0.039). Thirty-day and
90-day mortality increased with increasing age at diag-
nosis (p = 0.036). In unadjusted analyses, individuals
aged ≥60 years old, females, patients without formal edu-
cation, patients who were divorced or separated, severe
stroke NIHSS > 21, longer hospital stay > 14–29 days,
low GCS < 9 and HS type presented higher mortality
rates across 90-day follow up period compared to other
subgroups (Table 1).
Functional status and stroke severity
The majority 132(93%) of patients were fully independ-
ent (mRS 0–2) before stroke. On admission, mean NIHS
S was 15 (SD ±10.1) and 42(30%) of the patients had se-
vere stroke (NIHSS ≥21). The mean GCS was 12 (SD ±
2.8), and only 21 (15%) had GCS < 9 in all stroke, major-
ity with a GCS < 9 died within 1 month; 58 (41%) had
severe disability (mRS 4–5) at 30 days post-stroke and
38 (36%) at 90 days (Table 1).
Predictors of 30-day and 90-day mortality
Univariate analysis showed that age ≥ 60 years (uHR =
2.3, 95% CI: 1.03–5.16), smoking (uHR = 4.64, 95% CI:
1.11–19.4), stroke severity (NIHSS > 21) (uHR = 5.9, 95%
CI: 2.33–14.9), prolonged hospital stay of ≥14 days
(uHR = 2.64, 95% CI: 1.17–6.00), lower GCS < 9 (uHR =
4.71, 95% CI: 2.24–9.87), and poor functional status at
enrolment (mRS 4–5) (uHR = 4.89, 95% CI: 1.17–20.5),
significantly increased the risk of mortality at 30 days.
Age ≥ 60 years old (uHR = 1.95 (95% CI: 1.02–3.73), lon-
ger hospital stay of 14–29 days (uHR = 3.2 (95% CI:
1.53–6.78), lower GCS < 9 (uHR = 4.33, 95% CI: 2.24–
8.36), stroke severity (NIHSS ≥21) (uHR = 4.66 (95% CI:
2.26–9.58) and poor functional status at enrolment
(mRS 4–5) (uHR = 3.58, 95% CI: 1.28–10.0) increased
the risk of mortality at 90 days (Table 3).
After adjustment for age and sex in a multivariable
analysis, lower GCS < 9 (aHR =3.49 (95% CI: 1.39–8.75)
was a significant predictor of 30-day mortality, whereas
lower GCS of < 9 (aHR =4.34 (95% CI: 1.85–10.2), stroke
severity (NIHSS ≥21) (aHR) = 2.63 (95% CI: (1.68–10.5)
and haemorrhagic stroke type (aHR = 2.30, 95% CI:
1.13–4.66) were significant predictors of 90-day mortal-
ity. Shorter hospital stay (< 14 days) (aHR = 0.31 (95% CI:
0.11–0.93) and being married (aHR = 0.22 (95% CI:
0.06–0.84) were associated with reduced 30- and 90-day
mortality respectively (Table 3).
Discussion
In this study at a referral hospital in urban Uganda, the
overall short and medium term mortality associated with
stroke was relatively high compared to other settings
[23, 24] especially in the acute phase, and the functional
status of patients after stroke was poor. These results are
in accordance with findings from other studies in SSA
[5, 25], and confirm the trends reported by the global
burden of disease (GBD) study in 2013, regarding the
burden of stroke in SSA [7]. This suggests that there is
still much to be done in the prevention and management
of stroke, including the provision of specialized stroke
care for early competent care, as well as the establish-
ment of well-designed rehabilitation centres within the
SSA region.
The relatively high mortality rate in this study is com-
parable to other hospital based studies in SSA [9, 14]
and is substantially higher than observed in high-income
countries [23, 24]. The dissimilarities may be explained
by the differences in stroke care and management as
well as type of rehabilitation programs between coun-
tries. However in Uganda, the presence of continuum of
poverty [26] may lead to poor accessibility to hospital
care, late presentation of severe stroke and poor compli-
ance to medication with eventual poor health outcomes
[8]. A recent study in Uganda found that only 27% of
medicines and 32% of diagnostic tests for diabetes and
cardiovascular disease were affordable by most people
[27]. While poverty remains a long-term problem in
health care, simple interventions such as education of
patients and their caregivers in recognising early symp-
toms and improving referral systems can improve stroke
outcomes.
In addition to the high mortality, we also observed se-
vere disabilities among our patients during follow up.
The lack of stroke rehabilitation facilities, the inadequate
home-based care support for stroke patients and the
high levels of poverty within the communities [8, 28]
may also have contributed towards the poor outcomes
among our stroke patients. In this cohort, sometimes a
patient would be withdrawn from the hospital against
medical advice due to fear of the high medical bills [28].
Moreover, the majority of patients who participated in
this study catered for their own medical bills and only a
few had health insurance. A recent qualitative study [28]
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Table 1 Mortality rates according to socio demographic and clinical characteristics of patients with ischemic and haemorrhagic
stroke during 30-day and 90-day follow-up in Kampala, Uganda
Baseline characteristics Overall
mortality
N = 141
n (col %)
30-day
mortality
N = 136
(n (%))
30-day mortality rate
(95% CI) (Deaths/1000
person days)
P-value 90-day mortality
N = 90
(n (%))
90-day mortality rate
(95% CI) (Deaths/1000
person days)
P-Value
SOCIO DEMOGRAPHIC CHARACTERISTICS
Age (years) 0.036 0.039
-→ < 60 60 (43) 8 (5.8) 4.4 (2.21–8.83) 5 (5.6) 3.4 (1.96–5.82)
-→≥ 60 81 (57) 23 (16.9) 10.4 (6.93–15.7) 8 (8.9) 7.0 (4.92–9.96)
Gender 0.039 0.101
-→Male 48 (34) 7 (5.1) 3.9 (1.77–8.77) 5 (5.6) 3.6 (1.98–6.46)
-→ Female 93 (66) 24 (17.6) 10.0 (6.78–14.8) 8 (8.9) 6.3 (4.51–8.92)
Marital status 0.205 0.037
-Married 67 (48) 11 (8) 5.6 (3.08–10.0) 4 (4.4) 3.6 (2.15–5.92)
-Widowed 49 (35) 13 (9.5) 9.9 (5.76–17.1) 2 (2.2) 5.5 (3.34–9.18)
Divorced/separated 16 (11) 5 (3.7) 13.9 (6.24–30.9) 5 (5.5) 11.6 (6.22–21.5)
-Never married 9 (6) 2 (1.4) 3.42 (0.48–24.3) 2 (2.2) 8.1 (3.03–21.5)
Education level 0.396 0.823
-No education 20 (14) 6 (4.4) 10.9 (4.91–24.3) – 5.3 (2.38–11.8)
-Primary 56 (40) 8 (5.9) 5.5 (2.87–10.6) 8 (8.8) 4.7 (2.88–11.8)
-Secondary + 65 (46) 17 (12.5) 8.7 (5.34–14.2) 5 (5.5) 5.9 (3.87–8.93)
Smoking 0.020 0.125
-→ No 31 (22) 2 (1.5) 2.0 (0.50–8.05) 4 (4.4) 3.1 (1.40–6.92)
-→ Yes 110 (78) 29 (21.3) 9.6 (6.67–13.8) 9 (10.0) 6.0 (4.36–8.23)
Alcohol use 0.071 0.057
-Low risk drinkers 105 (74) 27 (19.9) 9.3 (6.37–13.5) 10 (11.1) 6.4 (4.64–8.83)
-Harmful/high risk 36 (26) 4 (2.9) 3.6 (1.36–9.60) 3 (3.3) 2.8 (1.34–5.89)
Family history of DM 0.634 0.901
-→ Yes 103 (73) 17 (12.5) 7.3 (4.71–11.2) 9 (10.0) 5.3 (3.70–7.48)
-→ No 38 (27) 14 (10.3) 8.7 (4.70–16.2) 4 (4.4) 5.5 (3.17–9.40)
Family history of HTN 0.906 0.557
-→ Yes 92 (65) 21 (15.4) 7.9 (5.20–12.2) 11 (12.2) 6.0 (4.26–8.52)
-→ No 33 (23) 7 (5.1) 7.9 (3.77–16.6) 1 (1.1) 4.3 (2.12–8.49)
-→Don’t know 16 (12) 3 (2.2) 6.0 (1.94–18.6) 1 (1.1) 3.7 (1.39–9.90)
CLINICAL CHARACTERISTICS
Self-reported history of HTN 0.995 0.563
-→ Yes 83 (59) 18 (13.2) 7.7 (4.92–12.1) 8 (8.8) 5.0 (3.39–7.42)
-→ No 58 (41) 13 (9.6) 7.7 (4.40–13.6) 5 (5.5) 5.8 (3.69–9.07)
Self-reported history of DM 0.489 0.333
-→ Yes 28 (20) 7 (5.1) 9.6 (4.78–19.1) 4 (4.4) 7.2 (4.08–12.6)
-→ No 113 (80) 24 (17.6) 7.2 (4.81–10.9) 9 (10) 4.9 (3.43–6.85)
BP ≥ 140/90 0.292 0.272
-→ Yes 82 (58) 21 (15.4) 8.9 (5.86–13.9) 9 (10.0) 6.1 (4.26–8.71)
-→ No 59 (42) 10 (7.4) 6.0 (3.20–11.1) 4 (4.4) 4.2 (2.48–7.06)
Obese 0.766 0.372
-→ Yes 29 (21) 6 (4.4) 6.9 (3.09–15.3) 1 (1.1) 4.0 (1.90–8.36)
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conducted in Uganda, found that some patients were
taken to churches or traditional healers for treatment
where they would eventually die or lost to follow up.
The concern is that, poor stroke outcomes may increase
in the region if interventions for prevention and post-
stroke care are not put in place.
The study also shows that mortality was particularly
high in the first 30 days, which is comparable to other
studies in SSA [5, 25]. Previous international research
has shown that after stroke, nearly two-thirds of patients
develop at least one complication [10, 29]. The
hematoma expansions, oedema formation, and intra-
ventricular haemorrhage leading to increased intracra-
nial pressure are likely contributors to the acute mortal-
ity [30]. These complications cannot be managed at
home or many of the primary care facilities available
across SSA. This suggests that interventions focusing on
prevention could potentially have the highest impact.
We also showed that lower GCS < 9 was a significant
predictor for both 30 and 90-day mortality and, that
Table 1 Mortality rates according to socio demographic and clinical characteristics of patients with ischemic and haemorrhagic
stroke during 30-day and 90-day follow-up in Kampala, Uganda (Continued)
Baseline characteristics Overall
mortality
N = 141
n (col %)
30-day
mortality
N = 136
(n (%))
30-day mortality rate
(95% CI) (Deaths/1000
person days)
P-value 90-day mortality
N = 90
(n (%))
90-day mortality rate
(95% CI) (Deaths/1000
person days)
P-Value
-→ No 112 (79) 25 (18.4) 7.9 (5.37–11.8) 12 (13.3) 5.7 (4.11–7.84)
HIV infection 0.294 0.751
-→ Yes 27 (19) 2 (1.5) 4.8 (1.79–12.7) 4 (4.4) 4.9 (2.46–9.84)
-→ No 114 (81) 27 (20.5) 8.5 (5.83–12.4) 9 (10.0) 5.4 (3.91–7.51)
Duration of hospitalization 0.015 0.004
Mean duration ±SD 9.4 (10.7)
- < 7 days 78 (55) 17 (12.5) 7.4 (4.54–12.1) 5 (5.5) 4.4 (2.89–6.80)
-7–13 days 37 (26) 6 (4.4) 4.3 (1.78–10.2) 5 (5.5) 4.7 (2.58–8.40)
-14–29 days 17 (12) 7 (5.2) 20.2 (10.5–38.8) 3 (3.3) 17.5 (9.7–31.6)
- ≥ 30 days 9 (7) 1 (0.5) 4.2 (0.59–30.0) – 1.8 (0.26–13.0)
Glasgow Coma Scale (GCS) < 0.001 < 0.001
Mean GCS ± SD 12 (2.8) 11.0 (3.2) 13.3 (2.4)
- < 9 21 (15) 11 (8.1) 28.6 (15.8–51.6) 2 (2.2) 20.9 (12.1–35.9)
- ≥ 9 120 (85) 20 (14.7) 5.5 (3.55–8.54) 11 (12.2) 4.1 (2.85–5.76)
Stroke severity at enrolment < 0.001
Mean NIHSS ±SD 15 (10.1) 20.0 (10.7) < 0.001 13.2 (9.0)
-NIHSS 0–12 66 (47) 7 (5.1) 2.8 (1.28–6.32) 4 (4.4) 2.4 (1.33–4.35)
-NIHSS 13–20 33 (23) 6 (4.4) 7.8 (3.74–16.4) 4 (4.4) 5.3 (2.87–9.91)
-NIHSS ≥21 42 (30) 18 (13.2) 17.9 (11.3–28.3) 5 (5.5) 12.6 (8.34–18.9)
Stroke type 0.079 0.123
Ischemic stroke 90 (64) 16 (11.8) 5.92 (3.63–9.67) 9 (10.0) 4.4 (2.98–6.53)
Hemorrhagic stroke 51 (36) 15 (11.0) 11.4 (6.89–18.9) 4 (4.4) 7.3 (4.65–11.4)
History of stroke 0.334 0.977
-Yes 20 (14) 6 (4.4) 11.3 (5.08–25.2) – 5.4 (3.90–7.37)
-No 121 (86) 25 (18.4) 7.2 (4.85–10.6) 13 (14.4) 5.1 (2.28–11.3)
Pre-stroke functional status 0.998 0.804
-mRS 0–2 132 (93) 29 (21.3) 7.7 (5.37–11.1) 12 (13.3) 5.3 (3.92–7.23)
-mRS 3 5 (4) 1 (0.7) 7.4 (1.04–52.2) 1 (1.1) 7.5 (1.87–29.0)
-mRS 4–5 4 (3) 1 (0.7) 7.9 (1.11–55.9) – 3.3 (0.46–23.1)
Functional status at enrolment 0.016 0.009
-mRS 0–3 31 (22) 2 (1.5) 1.9 (0.48–7.69) 2 (2.2) 1.8 (0.66–4.68)
-mRS 4–5 110 (78) 29 (21.3) 9.8 (6.77–14.0) 11 (12.2) 6.7 (4.89–9.09)
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stroke severity (NIHSS ≥21) and HS were significant
predictors of 90-day mortality. Similar correlations be-
tween GCS < 9, high NIHSS score (≥21), HS and mortal-
ity rates have been previously reported [13, 31]. In this
study, most of our participants were quite ill with mean
NIHSS significantly high and low levels of consciousness
(GCS < 9) on admission. In Africa, factors including long
distances to health care and poor accessibility to trans-
port are likely to lead to greater delay among patients
reaching hospital than in developed countries [8, 24].
The late presentation to care for our patients with severe
strokes has been reported to influence high mortality
particularly during the acute phase [32]. The develop-
ment of healthcare approaches that can allow early ac-
cess to specialized neurological care, availability of
rehabilitation, effective treatment, and improved know-
ledge on factors associated with a higher risk of death
should contribute to decreasing the considerable burden
of stroke in SSA. However, in this cohort, although
stroke patients had no access to formal rehabilitation
services in their communities, family members were
often dedicated in their provision of care to their loved
ones at home [28].
Consistent with previous findings [33], our study
showed that marriage provided a protective effect for
mortality at day 90. In developing countries like Uganda,
marriage can be viewed as a fundamental culture for car-
ing and supporting stroke survivors in the community
[34]. Some researchers suggest that this is partly because
spouses can provide some stable financial, social, and
psychological support after stroke [35]. Evidence from
one study [36] indicates that stroke survivors who re-
ceived high amounts of emotional support from their
spouses experienced superior functional recovery.
Mortality was higher in patients with HS compared to pa-
tients with IS, confirming existing reports in the SSA popu-
lation [37]. Reports have shown that HS is related to a
higher risk of acute complications such as hematoma ex-
pansion and intracranial hypertension than in patients with
IS, thus leading to severe strokes in these patients [38]. The
high proportion of HS deaths may also be largely explained
by the high prevalence of hypertension in the country along
with the low awareness and poor compliance to antihyper-
tensive therapies [39]. This finding reflects the need for
low-cost treatments to be made widely available in the
country, sufficient coverage of emergency services, surgical
interventions, improvement of the national referral system,
and intensive nationwide sensitization on stroke.
Our study had some limitations. First, this was a single
site hospital-based study in an urban setting, with a short
duration of recruitment and follow-up up to 90 days.
Therefore, the findings may not reflect the overall picture
of mortality in the population. Patients with very severe
Table 2 Cumulative mortality rates at 30 and 90-days according
to stroke type among ischemic and haemorrhagic stroke
patients in Kampala, Uganda
Mortality Rates/1000 Person days
Characteristic Person time
in days
Mortality
n (%)
Mortality rate
(95% CI)
Timing
Overall (at 90 days)
(n = 141)
8274.1 44 (31) 5.32 (3.96–7.15)
0–30 days (n = 136) 4015.1 31 (23) 7.72 (5.43–10.98)
31–90 days (n = 90) 4259.0 13 (14) 3.05 (1.39–4.71)
Stroke type
Hemorrhagic stroke
(n = 51)
2606.0 19 (37.3) 7.29 (4.65–11.43)
Ischemic stroke (n = 90) 5668.1 25 (27.8) 4.41 (2.98–6.53)
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Fig. 2 Cumulative stroke mortality among hemorrhagic and ischemic stroke patients at 90 days of follow up in Kampala, Uganda
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Table 3 Predictors of mortality in patients with ischemic and haemorrhagic stroke during a 30-day and 90-day follow up in
Kampala, Uganda
30 -day mortality 90 -day mortality
Variable uHR (95% CI) LRT
p-value
aHR (95%CI) uHR (95% CI) LRT
p-value
aHR (95%CI)
Age (years) 0.032 0.044
< 60 1 1 1
≥ 60 2.30 (1.03–5.14) 1.11 (0.45–2.75) 1.95 (1.02–3.73) 0.092 0.92 (0.41–2.06)
Gender, male 0.41 (0.17–0.98) 0.031 0.54 (0.20–1.46) 0.57 (0.29–1.13) 0.78 (0.32–1.90)
Marital status 0.222 0.063
-Never married 1 1 1
-Widowed 2.79 (0.36–21.3) 0.71 (0.24–2.14) 0.26 (0.07–1.01)
-Divorced/separated 3.89 (0.47–32.2) 1.42 (0.44–4.54) 0.32 (0.07–1.43)
-Married 1.59 (0.21–12.3) 0.46 (0.15–1.40) 0.22 (0.06–0.84)
Education level 0.395 0.824
-No education 1 1
-Primary 0.52 (0.18–1.46) 0.92 (0.36–2.34)
-Secondary & above 0.81 (0.32–2.07) 1.12 (0.45–2.76)
Smoking 0.009 0.105
No 1 1 1 1
Yes 4.64 (1.11–19.4) 3.85 (0.88–16.8) 1.96 (0.82–4.59) 1.68 (0.69–4.11)
BP ≥ 140/90 0.288 0.267
- No 1 1
- Yes 1.49 (0.70–3.17) 1.42 (0.75–2.69)
Obese 0.764 0.357
- No 1 1
- Yes 0.87 (0.36–2.13) 0.69 (0.31–1.56)
-HIV infection 0.270 0.749
- No 1 1
- Yes 0.58 (0.20–1.64) 0.88 (0.41–1.90)
-Length of hospital stay 0.040 0.017
- < 7 days 1 1 1 1
-7–13 days 0.58 (0.21–1.60) 0.31 (0.11–0.93) 1.03 (0.50–2.15) 0.55 (0.24–1.26)
-14–29 days 2.64 (1.17–6.00) 1.02 (0.37–2.81) 3.22 (1.53–6.78) 1.10 (0.42–2.82)
- ≥ 30 days 0.58 (0.08–4.36) 0.20 (0.02–1.71) 0.43 (0.06–3.18) 0.13 (0.02–1.06)
Glasgow Coma Scale < 0.001 < 0.001
- ≥ 9 1 1 1 1
- < 9 4.71 (2.24–9.87) 3.49 (1.39–8.75) 4.33 (2.24–8.36) 4.34 (1.85–10.2)
Stroke severity at enrolment < 0.001 < 0.001
-NIHSS 0–12 1 1 1 1
-NIHSS 13–20 2.71 (0.91–8.05) 1.48 (0.45–4.91) 2.24 (0.95–5.27) 1.85 (0.68–5.03)
-NIHSS ≥21 5.89 (2.33–14.8) 2.73 (0.85–8.80) 4.66 (2.26–9.58) 2.63 (1.68–10.5)
Pre-stroke functional status 0.998 0.798
-mRS 0–2a 1 1 1 1
-mRS 3 0.95 (0.13–7.00) 0.29 (0.03–2.84) 1.35 (0.33–5.60) 0.36 (0.07–1.79)
-mRS 4–5 1.03 (0.14–7.59) 0.37 (0.03–4.51) 0.61 (0.08–4.46) 0.40 (0.04–3.71)
Stroke type 0.089 0.133
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strokes may have died before reaching the hospital, whilst
mild self-limiting cases may never have presented for ad-
mission. Further population-based prospective studies are
warranted to evaluate longer term stroke mortality includ-
ing both urban and rural settings. Second, an inclusion
bias could have occurred attributable to the urban
hospital-based design of the study. The majority of the pa-
tients came from an urban population who could afford
hospitalization. Mortality rates may differ from a rural or
lower income population. Third, some patients were lost
to follow-up, and no outcome could be ascertained, which
may have led to underestimates of mortality. Fourth, some
of the predictor variable analyses were hampered by the
small sample size, with few cases of hemorrhagic stroke,
which made it difficult to identify possibly relevant predic-
tors. Fifth, blood pressure measurements were performed
upon admission, and should ideally have been repeated
outside of the acute window to exclude temporary ische-
mia induced hypertension. Finally, there was a lack of sub-
ject awareness of some stroke risk factors, and we
depended on the next of kin’s report for patients with se-
vere strokes.
Policy implications
Measures for secondary prevention of stroke, particularly
proper treatment, referral, and intensive follow-up in-
cluding drug compliance are desperately needed in Af-
rica. We hope that taking into account the predictors for
mortality for each stroke type in the present study, indi-
vidual patient management can be better optimized and
outcomes improved in Uganda. Further studies to exam-
ine the relationship between the type of stroke and im-
mediate cause of death are warranted. The knowledge of
the immediate cause of death and other contributory
factors will greatly enhance effective management of
acute stroke.
Conclusions
Mortality is high during the acute phase of stroke. Low
levels of consciousness, stroke severity, longer hospital
stay, and hemorrhagic stroke type were associated with
higher mortality in this cohort of Ugandan stroke pa-
tients. Being married was associated with lower 90-day
mortality. Given the high mortality during the acute
phase, critically ill stroke patients would benefit from
early interventions established as the post-stroke- stand-
ard of care in the country.
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